معرفی
Gaétan Mayer is a Professor at the Université de Montréal’s Faculty of Medicine and Faculty of Pharmacy, leading the Cellular and Molecular Biology of Lipoproteins Laboratory at the Montreal Heart Institute (ICM). His research focuses on PCSK9 mechanisms, lipid metabolism, and cardiovascular disease pathogenesis.
Education & Affiliations: Directs ICM’s therapeutic targets axis and Discovery & Validation of Therapeutic Targets axis at the Faculty of Pharmacy. Collaborates with the Quebec Drug Research Network (RQRM).
Research Interests: Atherosclerosis, LDL cholesterol regulation, metabolic syndrome, and drug discovery targeting PCSK9. Key projects include PCSK9 inhibitors, epigenetic modulation of LDLR, and lipid transport pathways in adipose and liver tissues.
Grants & Awards: Recipient of FRQS, CIHR, and Fonds de la Recherche du Québec grants. Notable awards include the Jonathan-Ballon New Researcher Award (2011) and Governor General’s Academic Gold Medal (2000).
Labs & Teams: Directs the Cellular and Molecular Biology of Lipoproteins lab, affiliated with ICM and GRUM (Drug Research Group). Supervises 6+ graduate students since 2015, focusing on PCSK9 biology, adipocyte metabolism, and epigenetic therapies.
